Jobs and Careers
LY
Research Associate II / Senior Research Associate, In-Vivo Pharmacology
Lycia Therapeutics, Inc.South San Francisco, United Statesfull_timeVerifiedPosted 10 Dec 2024
About the role
Lycia Therapeutics, Inc. is a biotechnology company leveraging its lysosomal targeting chimera (LYTAC) platform from Founder and Chemistry Nobel Laureate 2022, Carolyn Bertozzi, to discover and develop first-in-class therapeutics that degrade extracellular and membrane-bound proteins. Lycia’s next generation degraders harness the cell’s endogenous lysosomal trafficking and degradation machinery with the potential to degrade targets previously considered to be intractable, across a spectrum of indications. After raising $105 million in capital in 2021, Lycia is advancing an internal pipeline of novel degraders and has entered a strategic collaboration with Eli Lilly to address key unmet medical needs. In May 2024, Lycia Therapeutics completed a $106.6 million series C financing to advance its pipeline of LYTAC extracellular protein degraders to the clinic. Lycia is headquartered in South San Francisco.
Visit https://lyciatx.com/ for more information.
The Role:Lycia Therapeutics is seeking a self-motivated, organized, and technically skilled in vivo pharmacology Research Associate II or Senior Research Associate. The successful applicant will engage in innovative research in a dynamic team environment, with a focus on developing and executing in vivo studies to support target validation and drug discovery efforts. A passion for translating basic scientific insights into generation of novel therapeutics is a must.
Visit https://lyciatx.com/ for more information.
The Role:Lycia Therapeutics is seeking a self-motivated, organized, and technically skilled in vivo pharmacology Research Associate II or Senior Research Associate. The successful applicant will engage in innovative research in a dynamic team environment, with a focus on developing and executing in vivo studies to support target validation and drug discovery efforts. A passion for translating basic scientific insights into generation of novel therapeutics is a must.
Responsibilities:
- As part of the in vivo pharmacology team, conduct and support in vivo studies to evaluate pharmacokinetics, pharmacodynamics, efficacy, mechanism of action, and/or tolerability of novel therapeutics based on the LYTAC platform.
- Duties will include contribution to study design, drug administration, blood collection, IVIS imaging, surgical procedures, tissue dissection/processing, and monitoring of disease models.
- Evaluate, interpret, and document scientific results and communicate findings within functional and project teams.
- Collaborate with colleagues in cross-functional project teams to support drug discovery and drug development efforts for various pipeline and platform programs.
Requirements:
- B.S/B.A or M.S. in cell biology, molecular biology, biochemistry, pharmaceutical sciences, immunology, or related field with + 0 to 4 years of relevant experience. Previous industry experience is preferred.
- Proficiency with animal handling procedures (e.g., husbandry, dosing via multiple routes, blood collection, organ harvests, tissue processing, etc.). Substantial experience with intravenous dosing is a plus.
- Willingness to learn new in vivo techniques.
- Ability to work independently while contributing to an integrated team.
- Must be organized and detail-oriented with meticulous record keeping.
- Flexibility to contribute to multiple studies while remaining well organized.
- Highly motivated team player with excellent written and oral communication skills.
- Proficiency in standard software (e.g., MS office and GraphPad).
Apply for this role
Generate a tailored application kit with a matched cover letter, interview prep, and CV highlights — in under 60 seconds.
Apply Now →Generate Application KitFree account required — sign up in 30s